References of "Krzesinski, Jean-Marie"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailL'intérêt de la cystatine C dans l'évaluation de la fonction rénale
Delanaye, Pierre ULiege; Chapelle, Jean-Paul ULiege; Gielen, Jacques et al

in Nephrologie (2003), 24(8), 457-68

Glomerular filtration rate (GFR) is the best indicator of renal function. GFR is usually estimated by serum creatinine or the creatinine clearance calculated on urine collected over 24 hours or with the ... [more ▼]

Glomerular filtration rate (GFR) is the best indicator of renal function. GFR is usually estimated by serum creatinine or the creatinine clearance calculated on urine collected over 24 hours or with the Cockcroft formula. These methods are however limited. Serum creatinine has a very poor sensitivity and urine collection is difficult. Cystatin C is a protease inhibitor produced in a constant manner by nucleated cells. This molecule is freely filtrated by the glomerule and quite completely catabolized in the proximal tubules. Its plasmatic concentration might thus be used to estimate GFR. Presently available data allow to conclude that plasmatic cystatin C is at least as good as serum creatinine to estimate GFR. It is less sensible to changes in body mass. Its determination appears more sensitive to detect early mild changes in GFR. Reference values are presently available for the different methods of determination. Cystatin C plasma level determination is more expensive than routine creatinine plasma determination. In the absence of very significant advantages, this might explain its limited use in daily clinical practice. [less ▲]

Detailed reference viewed: 261 (4 ULiège)
Full Text
Peer Reviewed
See detailHypochromic mature erythrocytes: a specific marker of iron deficiency
Bovy, Christophe ULiege; Beguin, Yves ULiege; Gothot, André ULiege et al

in Acta Clinica Belgica (2003), 58-3(4), 325

Detailed reference viewed: 20 (2 ULiège)
Full Text
Peer Reviewed
See detailFollow-up of iron microalbuminuria in hypertensive patients: a belgian promise survey
Bovy, Christophe ULiege; Beguin, Yves ULiege; Gothot, André ULiege et al

in Acta Clinica Belgica (2003), 58-3(4), 328

Detailed reference viewed: 17 (1 ULiège)
Full Text
See detailRisque cardiovasculaire global: HOPE fait vivre plus longtemps
Krzesinski, Jean-Marie ULiege

in Tempo Médical (2003), 247

Les maladies cardiovasculaires restent la première cause de décès chez l'adulte; c'est dire l'importance d'une prise en charge adéquate du risque, notamment en médecine générale. A cet égard, les ... [more ▼]

Les maladies cardiovasculaires restent la première cause de décès chez l'adulte; c'est dire l'importance d'une prise en charge adéquate du risque, notamment en médecine générale. A cet égard, les recommandations les plus récentes vont de plus en plus dans le sens d'une prise en charge du risque cardiovasculaire global, accordant moins d'importance à la valeur absolue de chacun des facteurs de risque; les patients présentant le plus grand risque global devant, bien entendu, être prioritairement traités. Une attitude, basée sur les résultats de quelques grandes études cliniques, dont HOPE (Heart Outcomes Prevention Evaluation). Nous vous proposons ici un rappel des résultats de cette étude remarquable, ainsi qu'un commentaire sur cette nouvelle approche préventive du risque CV, en compagnie de quelques uns des orateurs du congrès Cardio 2003. [less ▲]

Detailed reference viewed: 28 (7 ULiège)
Full Text
See detailTotaal cardiovasculair risico: HOPE doet langer leven!
Krzesinski, Jean-Marie ULiege

in Tempo Médical (2003), 247

Cardiovasculaire aandoeningen blijven de belangrijkste doodsoorzaak bij volwassenen. Dat onderstreept het belang van een adequate behandeling van het risico, met name in de algemene geneeskunde. Oe meest ... [more ▼]

Cardiovasculaire aandoeningen blijven de belangrijkste doodsoorzaak bij volwassenen. Dat onderstreept het belang van een adequate behandeling van het risico, met name in de algemene geneeskunde. Oe meest recente aanbevelingen gaan steeds meer in de zin van een aanpak van het totale cardiovasculaire risico, waarbij minder belang wordt gehecht aan de absolute waarde van de atzonderlijke risicotactoren. Patienten met het grootste totale risico moeten uiteraard prioritair behandeld worden. Deze houding is gebaseerd op de resultaten van enkele grote klinische studies, waaronder HOPE (Heart Outcomes Prevention Evaluation). In dit artikel krijgt u een overzicht van de resultaten van deze opmerkelijke studie en een commentaar op deze nieuwe preventieve aanpak van het cardiovasculaire risico in het gezelschap van enkele sprekers op het congres Cardio 2003. [less ▲]

Detailed reference viewed: 22 (0 ULiège)
Full Text
Peer Reviewed
See detailLe contrôle de la pression artérielle chez le patient greffé rénal
Ait Oile, Fatima; Saint-Remy, Annie ULiege; Weekers, Laurent ULiege et al

in Archives des Maladies du Coeur et des Vaisseaux (2003), 96

Detailed reference viewed: 61 (3 ULiège)
Full Text
Peer Reviewed
See detailSyncope sur passage en tachycardie ventriculaire par accélération d’une fibrillation auriculaire
Guillaume, T.; Melon, Pierre ULiege; Bouffioux, Laurent ULiege et al

in Revue Médicale de Liège (2003), 58(7-8), 468-471

We report a rare case of rapid atrial fibrillation triggering an episod of ventricular tachycardia. We review the literature and discuss the potential mechanisms of the ventricular arrhythmia.

Detailed reference viewed: 91 (1 ULiège)
Full Text
See detailPrévention primaire des maladies rénales et secondaire de l'insuffisance rénale
Krzesinski, Jean-Marie ULiege; Rorive, Georges ULiege

in Médi-Sphère (2003), 192

Il est apparu important de rèsumer les points capitaux à respecter lors de tout contact avec un patient, d'une part pour le proteger du développement de la maladie rénale (si possible) et pour freiner l ... [more ▼]

Il est apparu important de rèsumer les points capitaux à respecter lors de tout contact avec un patient, d'une part pour le proteger du développement de la maladie rénale (si possible) et pour freiner l'évolution de celle-ci une fois constituée d'autre part, l'objectif étant alors d'éviter l'insuffisance rénale sévère, stade où l'intervention du médecin n'est plus que symptomatique. Généralement fortuite, l'insuffisance rénale gagne à être diagnostiquée précocement. L'intervention du néphrologue sera également d'autant plus efficace que rapide. [less ▲]

Detailed reference viewed: 57 (0 ULiège)
Full Text
See detailPrévention tertiaire de l'insuffisance rénale chronique chez l'adulte
Krzesinski, Jean-Marie ULiege; Rorive, Georges ULiege

in Médi-Sphère (2003), 197

L'insutfisance rénale chronique est une maladie méconnue, insidieuse, qui présente souvent peu je symptômes au début. Cet article veut insister sur les règles de bonne pratique pour freiner ou mieux ... [more ▼]

L'insutfisance rénale chronique est une maladie méconnue, insidieuse, qui présente souvent peu je symptômes au début. Cet article veut insister sur les règles de bonne pratique pour freiner ou mieux prévenir les complications de l'urémie et préparer si nécessaire le malade au traitement de suppléance. [less ▲]

Detailed reference viewed: 64 (0 ULiège)
See detailL'hypertension artérielle systolique isolée
Krzesinski, Jean-Marie ULiege

Conference (2002, October 12)

Detailed reference viewed: 9 (0 ULiège)
See detailEpidémiologie de l'insuffisance rénale chronique et risques cardio-vasculaires
Krzesinski, Jean-Marie ULiege

Conference (2002, October 09)

Detailed reference viewed: 8 (0 ULiège)
Full Text
Peer Reviewed
See detailDécompensation cardiaque, fonction rénale et anti-inflammatoires non stéroïdiens
Krzesinski, Jean-Marie ULiege; Piront, Patricia ULiege

in Revue Médicale de Liège (2002), 57(9), 582-586

Thanks to a case report of heart failure in an old people with a cardiovascular history treated by the new coxib-inhibitors, we would like to remember and insist to the risk of renal and cardiac ... [more ▼]

Thanks to a case report of heart failure in an old people with a cardiovascular history treated by the new coxib-inhibitors, we would like to remember and insist to the risk of renal and cardiac complications which appear to be the same as those with the non specific antiinflammatory drugs. Old age, diuretic or converting enzyme inhibitor treatment, heart failure, liver insufficiency, nephrotic syndrome are risk factors for acute renal failure and cardiac failure during such treatment. [less ▲]

Detailed reference viewed: 1123 (9 ULiège)
Full Text
Peer Reviewed
See detailHypertension artérielle et tachycardie: penser à regarder dans la pharmacie personnelle du patient
Krzesinski, Jean-Marie ULiege

in Revue Médicale de Liège (2002), 57(8), 497-501

The case report of a young patient with an increase in blood pressure and heart rate offers the opportunity to discuss the clinical guidelines to explore and treat high blood pressure. The value of the 24 ... [more ▼]

The case report of a young patient with an increase in blood pressure and heart rate offers the opportunity to discuss the clinical guidelines to explore and treat high blood pressure. The value of the 24 h blood pressure monitoring and the need for precise information on all drugs taken are stressed. [less ▲]

Detailed reference viewed: 799 (1 ULiège)
Full Text
Peer Reviewed
See detailComment j'explore.... Une hypertension resistante
Krzesinski, Jean-Marie ULiege

in Revue Médicale de Liège (2002), 57(7), 475-478

Hypertension is a cardiovascular risk factor which needs a good evaluation before treatment. When this latter is decided, the target is to normalize high blood pressure. This requires a complete ... [more ▼]

Hypertension is a cardiovascular risk factor which needs a good evaluation before treatment. When this latter is decided, the target is to normalize high blood pressure. This requires a complete information of the patient; the latter will also receive individualized non pharmacological advices and, also, possibly different antihypertensive drugs. When blood pressure does not normalize, one must check the blood pressure measurement technique, the compliance to treatment and potential pharmacologic interferences. Secondary hypertension is only considered if resistance to therapy cannot be found. It should be remembered that obesity and sleep apnea disorders are responsible of many instances of refractory hypertension. [less ▲]

Detailed reference viewed: 182 (5 ULiège)
See detailLa néphropathie diabétique
Krzesinski, Jean-Marie ULiege

Conference (2002, June 20)

Detailed reference viewed: 12 (0 ULiège)
See detailL'hypertension artérielle et son risque
Krzesinski, Jean-Marie ULiege

Conference (2002, June 02)

Detailed reference viewed: 3 (0 ULiège)
Full Text
Peer Reviewed
See detailHypertension artérielle et artériopathie
Krzesinski, Jean-Marie ULiege

in Revue Médicale de Liège (2002), 57(6), 370-374

High blood pressure as other factors of atherosclerosis is a well-known risk factor for development of peripheral arterial disease. A patient characterized by an isolated systolic hypertension and a low ... [more ▼]

High blood pressure as other factors of atherosclerosis is a well-known risk factor for development of peripheral arterial disease. A patient characterized by an isolated systolic hypertension and a low ankle/arm systolic blood pressure ratio very often presents coronary heart disease. Practising exercise (such as walking), stoping smoking and following an adapted diet are recommended. Hypertension treatment must be considered as a secondary prevention approach with a blood pressure normalisation as a target. All the different classes of antihypertensive drugs can be used, but with a marked preference for angiotensin converting enzyme (with caution for the renal artery stenosis risk) and for betablockers to improve the potential coronary heart disease (care is needed in the presence of severe peripheral arterial disease). [less ▲]

Detailed reference viewed: 135 (2 ULiège)
Full Text
Peer Reviewed
See detailDiagnostic criteria for renovascular hypertension
Krzesinski, Jean-Marie ULiege

in Acta Chirurgica Belgica (2002), 102(3), 159-166

Renovascular hypertension is a clinical situation characterized by high blood pressure in the presence of renal ischemia mainly related to atherosclerotic or fibromuscular dysplasic narrowing of the renal ... [more ▼]

Renovascular hypertension is a clinical situation characterized by high blood pressure in the presence of renal ischemia mainly related to atherosclerotic or fibromuscular dysplasic narrowing of the renal artery (ies). This diagnosis is often "a posteriori" validated, because the discovery of a significant renal artery stenosis is not obligatory responsible of the blood pressure elevation. This article proposes a diagnostic strategy for exploring patient with this suspected secondary cause of hypertension before proposing an invasive approach (intra-arterial angiography) possibly followed by a revascularization. However, the methods for exploring such population are mainly based on patient characteristics and local expertise and habits. These must thus be individualized. First, clinical symptoms or signs frequently associated with hypertension and renal artery stenosis must be searched. If present, a non invasive and functional exploration of the renal arteries is to be proposed (Captopril radioisotope renography, colour duplex sonography) followed by magnetic resonance angiography or spiral computer tomography angiography if the clinical suspicion index is moderate or high. If this is very high, an intra-arterial arteriography could immediately be performed if not too dangerous. On the opposite site, if the clinical index is low, it is recommended to follow clinically and to treat risk factors. [less ▲]

Detailed reference viewed: 36 (1 ULiège)
See detailIntérêt de mesurer la dysfonction endothéliale
Krzesinski, Jean-Marie ULiege

Conference (2002, May 18)

Detailed reference viewed: 3 (0 ULiège)
See detailL'hypertension artérielle chez le diabétique
Krzesinski, Jean-Marie ULiege

Conference (2002, May 16)

Detailed reference viewed: 16 (0 ULiège)